Ovarian cancer patients taking beta-blockers have better survival rates
Posted on Tuesday, September 22nd, 2015 at 4:44 pm by Williams Hart | Updated: Thursday, March 7th, 2019 at 5:04 pm
A retrospective study found that ovarian cancer patients who took certain types of drugs for hypertension had better survival rates than other women with the disease, an article from WebMD reported.
In a study of 1,425 cancer patients taking beta-blockers, scientists learned that women taking beta-2 and beta-3 blockers, or nonselective beta-blockers, lived for almost eight years on average after an ovarian cancer diagnosis, as compared to three years among those who did not take beta-blockers. According to research, beta-blockers are known to inhibit the effects of epinephrine, which promotes the growth of cancer cells.
However, a researcher at the U.S. National Cancer Institute, Dr. Christina Annuziata, warned ovarian cancer patients about the dangers of using beta-blockers when you don’t have high blood pressure.
The use of power morcellators during hysterectomies may spread undetected cancer tissues in the inside lining of the uterus, resulting in ovarian cancer. To know more about holding the device makers accountable for all of your damages, seek the legal guidance and representation of our legal team at Williams Hart. Call us at (800) 220-9341 for a free case assessment today.